Jaffetilchin Investment Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,816
| Closed | -$232K | – | 448 |
|
|
2025
Q1 | $232K | Buy |
1,816
+1
| +0.1% | +$128 | 0.02% | 369 |
|
|
2024
Q4 | $240K | Buy |
1,815
+1
| +0.1% | +$132 | 0.02% | 346 |
|
|
2024
Q3 | $264K | Buy |
1,814
+17
| +0.9% | +$2.48K | 0.02% | 312 |
|
|
2024
Q2 | $247K | Sell |
1,797
-23
| -1% | -$3.16K | 0.02% | 302 |
|
|
2024
Q1 | $250K | Buy |
1,820
+4
| +0.2% | +$549 | 0.02% | 314 |
|
|
2023
Q4 | $247K | Sell |
1,816
-1,355
| -43% | -$184K | 0.02% | 303 |
|
|
2023
Q3 | $388K | Hold |
3,171
| – | – | 0.04% | 235 |
|
|
2023
Q2 | $403K | Sell |
3,171
-10,922
| -77% | -$1.39M | 0.04% | 229 |
|
|
2023
Q1 | $1.82M | Sell |
14,093
-61
| -0.4% | -$7.88K | 0.21% | 87 |
|
|
2022
Q4 | $1.86M | Buy |
14,154
+6,035
| +74% | +$792K | 0.23% | 86 |
|
|
2022
Q3 | $950K | Sell |
8,119
-35
| -0.4% | -$4.1K | 0.12% | 109 |
|
|
2022
Q2 | $959K | Buy |
8,154
+1,130
| +16% | +$133K | 0.11% | 123 |
|
|
2022
Q1 | $769K | Sell |
7,024
-33,190
| -83% | -$3.63M | 0.09% | 144 |
|
|
2021
Q4 | $6.14M | Buy |
40,214
+711
| +2% | +$109K | 0.58% | 39 |
|
|
2021
Q3 | $6.39M | Sell |
39,503
-21,868
| -36% | -$3.54M | 0.68% | 32 |
|
|
2021
Q2 | $9.74M | Buy |
61,371
+30,408
| +98% | +$4.83M | 0.67% | 30 |
|
|
2021
Q1 | $4.66M | Buy |
30,963
+6,118
| +25% | +$921K | 0.55% | 40 |
|
|
2020
Q4 | $3.76M | Buy |
+24,845
| New | +$3.76M | 0.53% | 30 |
|
|
2019
Q2 | – | Sell |
-9,267
| Closed | -$1.04M | – | 296 |
|
|
2019
Q1 | $1.04M | Hold |
9,267
| – | – | 0.23% | 68 |
|
|
2018
Q4 | $894K | Sell |
9,267
-749
| -7% | -$72.3K | 0.22% | 62 |
|
|
2018
Q3 | $1.22M | Buy |
+10,016
| New | +$1.22M | 0.26% | 68 |
|
|
2017
Q2 | – | Sell |
-2,259
| Closed | -$221K | – | 256 |
|
|
2017
Q1 | $221K | Buy |
+2,259
| New | +$221K | 0.06% | 232 |
|